Schedule 13D ownership disclosure

SAB BIOTHERAPEUTICS INC

Security class unavailable · CUSIP: 78397T103

Event date: 2022-12-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,712,045
Percent of class
17.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-22-026678
Form type
SC 13D/A
Filer
HAMILTON CHRISTINE E
CIK
CIK 1216114
Filed
Dec 16, 2022
Reporting period
Dec 07, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub